Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Registry for understanding chronic subdural hematoma

Official title: Registry of Chronic Subdural Hematoma

Run by Erasmus Medical Center · NCT06759428 · Data updated 2026-11-12

This study is looking to gather information from adults with chronic subdural hematoma to see how different treatments work and improve care for future patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations2 sites (Amsterdam and 1 other locations)
StatusRecruiting
StartedOctober 1, 2021
Main results expectedOctober 2027
Study endsJanuary 2028
Registry record updatedJanuary 7, 2025
Trial IDNCT06759428 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have been diagnosed with chronic subdural hematoma.

Probably not a fit

Patients who do not consent to participate in the registry will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather detailed information on chronic subdural hematoma (CSDH) by examining patient characteristics at diagnosis, treatment strategies employed, and outcomes following treatment. It will involve adult patients diagnosed with CSDH who will receive standard care and participate in a follow-up telephone interview three months post-treatment. The study seeks to address variability in management practices and improve evidence-based guidelines for CSDH treatment.

Why it matters

Potential benefit: If successful, this study could enhance understanding of CSDH management and improve patient outcomes through better-informed treatment guidelines.

How similar studies have gone: While there is ongoing research in the field, this registry approach is novel in its focus on observational data collection for CSDH management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with CSDH
* 18 years or older

Exclusion Criteria:

* Patients who do not consent to participate in the registry

Where it's running

  • Amsterdam UMC
    Amsterdam, Netherlands
    Recruiting
  • Erasmus MC
    Rotterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.